|
TOMM22 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.13367126586672E-13 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.24229515563457E-11 |
| Normal-vs-Stage2 |
5.862900E-03 |
| Normal-vs-Stage3 |
4.30490088021429E-11 |
| Normal-vs-Stage4 |
2.80475642711053E-12 |
| Stage1-vs-Stage2 |
2.104200E-01 |
| Stage1-vs-Stage3 |
4.358000E-01 |
| Stage1-vs-Stage4 |
7.584000E-03 |
| Stage2-vs-Stage3 |
1.067010E-01 |
| Stage2-vs-Stage4 |
3.923900E-03 |
| Stage3-vs-Stage4 |
4.544400E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.56483723148904E-12 |
| Normal-vs-AfricanAmerican |
1.41890000004974E-06 |
| Normal-vs-Asian |
1.16360000523841E-08 |
| Caucasian-vs-AfricanAmerican |
8.168400E-02 |
| Caucasian-vs-Asian |
3.138600E-01 |
| AfricanAmerican-vs-Asian |
3.955200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.33559896054703E-11 |
| Normal-vs-Female |
3.59712259978551E-12 |
| Male-vs-Female |
5.818400E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.60218538225854E-12 |
| Normal-vs-Age(41-60Yrs) |
3.05644398679306E-13 |
| Normal-vs-Age(61-80Yrs) |
1.81909999952268E-07 |
| Normal-vs-Age(81-100Yrs) |
2.012200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.663000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.775800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.259700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.161800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.736100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.471600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.615400E-01 |
| Classical-VS-Follicular |
1.824780E-01 |
| Classical-VS-Other |
5.713400E-01 |
| Classical-VS-Normal |
2.12285744538576E-12 |
| Tall-VS-Follicular |
1.669980E-01 |
| Tall-VS-Other |
6.581600E-01 |
| Tall-VS-Normal |
2.66890000100162E-08 |
| Follicular-VS-Other |
2.820000E-01 |
| Follicular-VS-Normal |
1.196440E-04 |
| Other-VS-Normal |
7.409800E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.91359999962759E-09 |
| Normal-vs-N1 |
1.04530051281415E-10 |
| N0-vs-N1 |
1.586220E-02 |
|
|
